(E)-4-(2-methoxy-4-methylphenoxy)-N-(4-morpholinophenyl)-5-((3,5-dichlorobenzylidene)amino)pyrimidin-2-amine

ID: ALA4172630

PubChem CID: 137365243

Max Phase: Preclinical

Molecular Formula: C29H27Cl2N5O3

Molecular Weight: 564.47

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C)ccc1Oc1nc(Nc2ccc(N3CCOCC3)cc2)ncc1/N=C/c1cc(Cl)cc(Cl)c1

Standard InChI:  InChI=1S/C29H27Cl2N5O3/c1-19-3-8-26(27(13-19)37-2)39-28-25(32-17-20-14-21(30)16-22(31)15-20)18-33-29(35-28)34-23-4-6-24(7-5-23)36-9-11-38-12-10-36/h3-8,13-18H,9-12H2,1-2H3,(H,33,34,35)/b32-17+

Standard InChI Key:  NGHCAKYPVLEHKE-VTNSRFBWSA-N

Molfile:  

     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
   19.5699  -20.3348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5688  -21.1544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2768  -21.5633    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.9865  -21.1539    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9836  -20.3312    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2750  -19.9260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2726  -19.1088    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.9791  -18.6981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6859  -19.1069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3919  -18.6969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3899  -17.8788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6760  -17.4725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9729  -17.8849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6948  -21.5614    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.4019  -21.1517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.1069  -21.5596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8135  -21.1506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8126  -20.3325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0993  -19.9252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3957  -20.3365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8621  -19.9264    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.1545  -20.3352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4490  -19.9272    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4501  -19.1089    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7431  -18.7006    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0346  -19.1094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0374  -19.9308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7449  -20.3355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0958  -17.4672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2623  -17.4814    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.2564  -16.6642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5136  -19.9230    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.2224  -20.3317    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9268  -19.9245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9287  -19.1070    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.2199  -18.6983    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5093  -19.1071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7433  -17.8834    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   15.3312  -20.3421    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
  4 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  1 21  1  0
 21 22  2  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 22 23  1  0
 11 29  1  0
 13 30  1  0
 30 31  1  0
 32 33  1  0
 32 37  1  0
 33 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 18 32  1  0
 25 38  1  0
 27 39  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4172630

    ---

Associated Targets(Human)

LCK Tclin Tyrosine-protein kinase LCK (9212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 564.47Molecular Weight (Monoisotopic): 563.1491AlogP: 7.22#Rotatable Bonds: 8
Polar Surface Area: 81.10Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 2.67CX LogP: 7.59CX LogD: 7.59
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.23Np Likeness Score: -1.52

References

1. Farag AK, Elkamhawy A, Londhe AM, Lee KT, Pae AN, Roh EJ..  (2017)  Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders.,  141  [PMID:29107425] [10.1016/j.ejmech.2017.10.003]

Source